Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and …

RS McIntyre, JD Rosenblat… - American Journal of …, 2021 - Am Psychiatric Assoc
Replicated international studies have underscored the human and societal costs associated
with major depressive disorder. Despite the proven efficacy of monoamine-based …

Asymmetric organocatalysis: an enabling technology for medicinal chemistry

B Han, XH He, YQ Liu, G He, C Peng… - Chemical Society Reviews, 2021 - pubs.rsc.org
The efficacy and synthetic versatility of asymmetric organocatalysis have contributed
enormously to the field of organic synthesis since the early 2000s. As asymmetric …

Experimenters' sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor

P Georgiou, P Zanos, TCM Mou, X An… - Nature …, 2022 - nature.com
We show that the sex of human experimenters affects mouse behaviors and responses
following administration of the rapid-acting antidepressant ketamine and its bioactive …

Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis

A Bahji, GH Vazquez, CA Zarate Jr - Journal of affective disorders, 2021 - Elsevier
Background Ketamine appears to have a therapeutic role in certain mental disorders, most
notably depression. However, the comparative performance of different formulations of …

Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine

W Yao, Q Cao, S Luo, L He, C Yang, J Chen, Q Qi… - Molecular …, 2022 - nature.com
Abstract (R, S)-ketamine elicits rapid-acting and sustained antidepressant actions in
treatment-resistant patients with depression.(R)-ketamine produces longer-lasting …

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability

J Bonaventura, S Lam, M Carlton, MA Boehm… - Molecular …, 2021 - nature.com
Ketamine, a racemic mixture of (S)-ketamine and (R)-ketamine enantiomers, has been used
as an anesthetic, analgesic and more recently, as an antidepressant. However, ketamine …

[HTML][HTML] Antidepressant drugs act by directly binding to TRKB neurotrophin receptors

PC Casarotto, M Girych, SM Fred, V Kovaleva… - Cell, 2021 - cell.com
It is unclear how binding of antidepressant drugs to their targets gives rise to the clinical
antidepressant effect. We discovered that the transmembrane domain of tyrosine kinase …

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor

Y Wei, L Chang, K Hashimoto - Molecular Psychiatry, 2022 - nature.com
The discovery of robust antidepressant actions exerted by the N-methyl-D-aspartate receptor
(NMDAR) antagonist (R, S)-ketamine has been a crucial breakthrough in mood disorder …

Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis

Y Alnefeesi, D Chen-Li, E Krane, MY Jawad… - Journal of psychiatric …, 2022 - Elsevier
Ketamine is a promising therapeutic option in treatment-resistant depression (TRD). The
acute efficacy of ketamine in TRD has been demonstrated in replicated randomised …

A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder

A Feder, S Costi, SB Rutter, AB Collins… - American Journal of …, 2021 - Am Psychiatric Assoc
Objective: Posttraumatic stress disorder (PTSD) is a chronic and disabling disorder, for
which available pharmacotherapies have limited efficacy. The authors' previous proof-of …